ACRV - Acrivon Therapeutics Inc
1.66
0.060 3.614%
Share volume: 520,286
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.60
0.06
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-27-2025 | 05-14-2025 | 11-13-2025 | |
| Cash flow financing | -172.000 K | 123.350 M | -1.504 M | -647.000 K | -343.000 K | -117.000 K | |
| Other financing cash flows | -87.000 K | -499.000 K | -1.197 M | -647.000 K | -343.000 K | -117.000 K | |
| Cash flow | -11.405 M | 21.403 M | -2.816 M | -3.595 M | -664.000 K | -6.489 M | |
| Net income | -16.486 M | -18.798 M | -22.441 M | -22.831 M | -19.680 M | -18.234 M | |
| Depreciation | 224.000 K | 228.000 K | 251.000 K | 303.000 K | 311.000 K | 349.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 5.850 M | -88.044 M | 16.011 M | 14.412 M | 19.214 M | 5.911 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 815.000 K | 137.000 K | 989.000 K | 827.000 K | 58.000 K | 899.000 K | |
| Cash Change | -11.405 M | 21.403 M | -2.816 M | -3.595 M | -664.000 K | -6.489 M |